ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,811, issued on June 10, was assigned to CIPLA Ltd. (Mumabi, India).
"Intranasal formulation" was invented by Geena Malhotra (Mumbai, India), Sarabjit Singh (Thane, India), Kalindi Gandhi (Mumbai, India) and Vipul Mittal (Thane, India).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the formulation of midazolam. In particular, the invention provides new midazolam formulation for intranasal administration. These formulations contain midazolam in a high concentration from about 1% to about 10% w/w of the formulation and process of preparation thereof."
The patent was filed on Dec. 18, 2019, under Application No. 17/415,9...